0001437749-24-004361.txt : 20240215
0001437749-24-004361.hdr.sgml : 20240215
20240215161727
ACCESSION NUMBER: 0001437749-24-004361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krempa David
CENTRAL INDEX KEY: 0001968254
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38738
FILM NUMBER: 24644034
MAIL ADDRESS:
STREET 1: 29125 W FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
BUSINESS PHONE: (847) 787-7361
MAIL ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-02-13
0001710340
Eton Pharmaceuticals, Inc.
ETON
0001968254
Krempa David
C/O ETON PHARMACEUTICALS, INC.
21925 W. FIELD PARKWAY, SUITE 235
DEERPARK
IL
60010-7208
1
Chief Business Officer
0
Stock Option (Right to buy)
4.42
2024-02-13
4
A
0
144677
0
A
2034-02-12
Common Stock
144677
813430
D
The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.
The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.
/s/ David Krempa
2024-02-15